APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug-Device Combination Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug-Device Combination Products Industry Growth and Trends Forecast to 2032

19 December 2025121 pages

Choose your research edition.

Industry ResearchDrug-Device Combination Products Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug-Device Combination Products Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug-Device Combination Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug-Device Combination Products Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug-Device Combination Products Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

According to APO Research, the global Drug-Device Combination Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug-Device Combination Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug-Device Combination Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug-Device Combination Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drug-Device Combination Products market include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug-Device Combination Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug-Device Combination Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug-Device Combination Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug-Device Combination Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug-Device Combination Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug-Device Combination Products Market by Company

GSK

Novo Nordisk

Eli Lilly

AstraZeneca

Sanofi

Boston Scientific

Abbott

Boehringer Ingelheim

Medtronic

Mylan

3M

Hisamitsu

Smith & Nephew

Molnlycke

Teleflex

BD

Lepu Medical

MicroPort

Terumo

B. Braun

Antares Pharma

Drug-Device Combination Products Segment by Type

Drug-Coated Device

Prefilled Drug Delivery Systems

Nebulizer and Inhaler

Transdermal Delivery System

Others

Drug-Device Combination Products Segment by Application

Hospital andClinic

Retail Pharmacies

Other

Drug-Device Combination Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Device Combination Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-Device Combination Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Device Combination Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug-Device Combination Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug-Device Combination Products Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug-Device Combination Products Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug-Device Combination Products Market Share by Region (2021-2026) Table 4. Global Drug-Device Combination Products Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug-Device Combination Products Market Share by Region (2027-2032) Table 6. Global Drug-Device Combination Products Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug-Device Combination Products Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug-Device Combination Products Market Size Share by Type (2021-2026) Table 9. Global Drug-Device Combination Products Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug-Device Combination Products Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug-Device Combination Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug-Device Combination Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug-Device Combination Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug-Device Combination Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug-Device Combination Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug-Device Combination Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug-Device Combination Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug-Device Combination Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug-Device Combination Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug-Device Combination Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug-Device Combination Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug-Device Combination Products Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug-Device Combination Products Market Size Share by Application (2021-2026) Table 24. Global Drug-Device Combination Products Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug-Device Combination Products Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug-Device Combination Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug-Device Combination Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug-Device Combination Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug-Device Combination Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug-Device Combination Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug-Device Combination Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug-Device Combination Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug-Device Combination Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug-Device Combination Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug-Device Combination Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug-Device Combination Products Industry Trends Table 37. Drug-Device Combination Products Industry Drivers Table 38. Drug-Device Combination Products Industry Opportunities and Challenges Table 39. Drug-Device Combination Products Industry Restraints Table 40. Global Drug-Device Combination Products Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug-Device Combination Products Revenue Market Share by Company (2021-2026) Table 42. Global Drug-Device Combination Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug-Device Combination Products Key Company Headquarters & Area Served Table 44. Global Drug-Device Combination Products Company, Product Type & Application Table 45. Global Drug-Device Combination Products Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug-Device Combination Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GSK Company Information Table 49. GSK Business Overview Table 50. GSK Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GSK Drug-Device Combination Products Product Portfolio Table 52. GSK Recent Development Table 53. Novo Nordisk Company Information Table 54. Novo Nordisk Business Overview Table 55. Novo Nordisk Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novo Nordisk Drug-Device Combination Products Product Portfolio Table 57. Novo Nordisk Recent Development Table 58. Eli Lilly Company Information Table 59. Eli Lilly Business Overview Table 60. Eli Lilly Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Eli Lilly Drug-Device Combination Products Product Portfolio Table 62. Eli Lilly Recent Development Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AstraZeneca Drug-Device Combination Products Product Portfolio Table 67. AstraZeneca Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sanofi Drug-Device Combination Products Product Portfolio Table 72. Sanofi Recent Development Table 73. Boston Scientific Company Information Table 74. Boston Scientific Business Overview Table 75. Boston Scientific Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Boston Scientific Drug-Device Combination Products Product Portfolio Table 77. Boston Scientific Recent Development Table 78. Abbott Company Information Table 79. Abbott Business Overview Table 80. Abbott Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Abbott Drug-Device Combination Products Product Portfolio Table 82. Abbott Recent Development Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Drug-Device Combination Products Product Portfolio Table 87. Boehringer Ingelheim Recent Development Table 88. Medtronic Company Information Table 89. Medtronic Business Overview Table 90. Medtronic Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Medtronic Drug-Device Combination Products Product Portfolio Table 92. Medtronic Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Mylan Drug-Device Combination Products Product Portfolio Table 97. Mylan Recent Development Table 98. 3M Company Information Table 99. 3M Business Overview Table 100. 3M Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. 3M Drug-Device Combination Products Product Portfolio Table 102. 3M Recent Development Table 103. Hisamitsu Company Information Table 104. Hisamitsu Business Overview Table 105. Hisamitsu Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Hisamitsu Drug-Device Combination Products Product Portfolio Table 107. Hisamitsu Recent Development Table 108. Smith & Nephew Company Information Table 109. Smith & Nephew Business Overview Table 110. Smith & Nephew Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Smith & Nephew Drug-Device Combination Products Product Portfolio Table 112. Smith & Nephew Recent Development Table 113. Molnlycke Company Information Table 114. Molnlycke Business Overview Table 115. Molnlycke Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Molnlycke Drug-Device Combination Products Product Portfolio Table 117. Molnlycke Recent Development Table 118. Teleflex Company Information Table 119. Teleflex Business Overview Table 120. Teleflex Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Teleflex Drug-Device Combination Products Product Portfolio Table 122. Teleflex Recent Development Table 123. BD Company Information Table 124. BD Business Overview Table 125. BD Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. BD Drug-Device Combination Products Product Portfolio Table 127. BD Recent Development Table 128. Lepu Medical Company Information Table 129. Lepu Medical Business Overview Table 130. Lepu Medical Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Lepu Medical Drug-Device Combination Products Product Portfolio Table 132. Lepu Medical Recent Development Table 133. MicroPort Company Information Table 134. MicroPort Business Overview Table 135. MicroPort Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. MicroPort Drug-Device Combination Products Product Portfolio Table 137. MicroPort Recent Development Table 138. Terumo Company Information Table 139. Terumo Business Overview Table 140. Terumo Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Terumo Drug-Device Combination Products Product Portfolio Table 142. Terumo Recent Development Table 143. B. Braun Company Information Table 144. B. Braun Business Overview Table 145. B. Braun Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. B. Braun Drug-Device Combination Products Product Portfolio Table 147. B. Braun Recent Development Table 148. Antares Pharma Company Information Table 149. Antares Pharma Business Overview Table 150. Antares Pharma Drug-Device Combination Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Antares Pharma Drug-Device Combination Products Product Portfolio Table 152. Antares Pharma Recent Development Table 153. North America Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Drug-Device Combination Products Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Drug-Device Combination Products Market Share by Country (2021-2026) Table 156. North America Drug-Device Combination Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Drug-Device Combination Products Market Share Forecast by Country (2027-2032) Table 158. Europe Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Drug-Device Combination Products Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Drug-Device Combination Products Market Share by Country (2021-2026) Table 161. Europe Drug-Device Combination Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Drug-Device Combination Products Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Drug-Device Combination Products Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Drug-Device Combination Products Market Share by Country (2021-2026) Table 166. Asia-Pacific Drug-Device Combination Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Drug-Device Combination Products Market Share Forecast by Country (2027-2032) Table 168. Latin America Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Drug-Device Combination Products Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Drug-Device Combination Products Market Share by Country (2021-2026) Table 171. Latin America Drug-Device Combination Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Drug-Device Combination Products Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Drug-Device Combination Products Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Drug-Device Combination Products Market Share by Country (2021-2026) Table 176. Middle East & Africa Drug-Device Combination Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Drug-Device Combination Products Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug-Device Combination Products Product Image Figure 3. Global Drug-Device Combination Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug-Device Combination Products Market Share by Region: 2025 VS 2032 Figure 6. Global Drug-Device Combination Products Market Share by Region (2021-2032) Figure 7. North America Drug-Device Combination Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug-Device Combination Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug-Device Combination Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug-Device Combination Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug-Device Combination Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Drug-Coated Device Image Figure 13. Global Drug-Coated Device Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Prefilled Drug Delivery Systems Image Figure 15. Global Prefilled Drug Delivery Systems Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Nebulizer and Inhaler Image Figure 17. Global Nebulizer and Inhaler Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Transdermal Delivery System Image Figure 19. Global Transdermal Delivery System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Drug-Device Combination Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Drug-Device Combination Products Market Share by Type 2025 VS 2032 Figure 24. North America Drug-Device Combination Products Market Size Share by Type (2021-2032) Figure 25. Europe Drug-Device Combination Products Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Drug-Device Combination Products Market Size Share by Type (2021-2032) Figure 27. Latin America Drug-Device Combination Products Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Drug-Device Combination Products Market Size Share by Type (2021-2032) Figure 29. Hospital andClinic Image Figure 30. Global Hospital andClinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Drug-Device Combination Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Drug-Device Combination Products Market Share by Application 2025 VS 2032 Figure 37. North America Drug-Device Combination Products Market Size Share by Application (2021-2032) Figure 38. Europe Drug-Device Combination Products Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Drug-Device Combination Products Market Size Share by Application (2021-2032) Figure 40. Latin America Drug-Device Combination Products Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Drug-Device Combination Products Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Drug-Device Combination Products Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Drug-Device Combination Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Drug-Device Combination Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Drug-Device Combination Products Market Share by Country (2021-2032) Figure 47. Europe Drug-Device Combination Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Drug-Device Combination Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Drug-Device Combination Products Market Share by Country (2021-2032) Figure 50. Asia-Pacific Drug-Device Combination Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Drug-Device Combination Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Drug-Device Combination Products Market Share by Country (2021-2032) Figure 53. Latin America Drug-Device Combination Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Drug-Device Combination Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Drug-Device Combination Products Market Share by Country (2021-2032) Figure 56. Middle East & Africa Drug-Device Combination Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Drug-Device Combination Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Drug-Device Combination Products Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Drug-Coated Device
  • Prefilled Drug Delivery Systems
  • Nebulizer and Inhaler
  • Transdermal Delivery System
  • Others
Applications
  • Hospital andClinic
  • Retail Pharmacies
  • Other
Companies covered
  • GSK
  • Novo Nordisk
  • Eli Lilly
  • AstraZeneca
  • Sanofi
  • Boston Scientific
  • Abbott
  • Boehringer Ingelheim
  • Medtronic
  • Mylan
  • 3M
  • Hisamitsu
  • Smith & Nephew
  • Molnlycke
  • Teleflex
  • BD
  • Lepu Medical
  • MicroPort
  • Terumo
  • B. Braun
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug-Device Combination Products Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug-Device Combination Products Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug-Device Combination Products Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug-Device Combination Products Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug-Device Combination Products Market Size (2021-2032)
  8. 1.5.1 North America Drug-Device Combination Products Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug-Device Combination Products Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug-Device Combination Products Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug-Device Combination Products Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug-Device Combination Products Market Size Growth Rate (2021-2032)
2 Drug-Device Combination Products Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Drug-Coated Device
  3. 2.1.2 Prefilled Drug Delivery Systems
  4. 2.1.3 Nebulizer and Inhaler
  5. 2.1.4 Transdermal Delivery System
  6. 2.1.5 Others
  7. 2.2 Global Drug-Device Combination Products Market Size by Type
  8. 2.2.1 Global Drug-Device Combination Products Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Drug-Device Combination Products Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Drug-Device Combination Products Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Drug-Device Combination Products Market Size by Regions
  12. 2.3.1 North America Drug-Device Combination Products Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Drug-Device Combination Products Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Drug-Device Combination Products Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Drug-Device Combination Products Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Drug-Device Combination Products Market Size Breakdown by Type (2021-2026)
3 Drug-Device Combination Products Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital andClinic
  3. 3.1.2 Retail Pharmacies
  4. 3.1.3 Other
  5. 3.2 Global Drug-Device Combination Products Market Size by Application
  6. 3.2.1 Global Drug-Device Combination Products Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Drug-Device Combination Products Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Drug-Device Combination Products Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Drug-Device Combination Products Market Size by Regions
  10. 3.3.1 North America Drug-Device Combination Products Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Drug-Device Combination Products Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Drug-Device Combination Products Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Drug-Device Combination Products Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Drug-Device Combination Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug-Device Combination Products Industry Trends
  2. 4.2 Drug-Device Combination Products Industry Drivers
  3. 4.3 Drug-Device Combination Products Industry Opportunities and Challenges
  4. 4.4 Drug-Device Combination Products Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug-Device Combination Products Revenue (2021-2026)
  2. 5.2 Global Drug-Device Combination Products Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug-Device Combination Products Key Company Headquarters & Area Served
  4. 5.4 Global Drug-Device Combination Products Company, Product Type & Application
  5. 5.5 Global Drug-Device Combination Products Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug-Device Combination Products Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug-Device Combination Products Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug-Device Combination Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GSK Drug-Device Combination Products Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Drug-Device Combination Products Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Drug-Device Combination Products Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Drug-Device Combination Products Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Drug-Device Combination Products Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Boston Scientific
  32. 6.6.1 Boston Scientific Company Information
  33. 6.6.2 Boston Scientific Business Overview
  34. 6.6.3 Boston Scientific Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Boston Scientific Drug-Device Combination Products Product Portfolio
  36. 6.6.5 Boston Scientific Recent Developments
  37. 6.7 Abbott
  38. 6.7.1 Abbott Company Information
  39. 6.7.2 Abbott Business Overview
  40. 6.7.3 Abbott Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Abbott Drug-Device Combination Products Product Portfolio
  42. 6.7.5 Abbott Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Boehringer Ingelheim Drug-Device Combination Products Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
  49. 6.9 Medtronic
  50. 6.9.1 Medtronic Company Information
  51. 6.9.2 Medtronic Business Overview
  52. 6.9.3 Medtronic Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Medtronic Drug-Device Combination Products Product Portfolio
  54. 6.9.5 Medtronic Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Drug-Device Combination Products Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 3M
  62. 6.11.1 3M Company Information
  63. 6.11.2 3M Business Overview
  64. 6.11.3 3M Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 3M Drug-Device Combination Products Product Portfolio
  66. 6.11.5 3M Recent Developments
  67. 6.12 Hisamitsu
  68. 6.12.1 Hisamitsu Company Information
  69. 6.12.2 Hisamitsu Business Overview
  70. 6.12.3 Hisamitsu Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Hisamitsu Drug-Device Combination Products Product Portfolio
  72. 6.12.5 Hisamitsu Recent Developments
  73. 6.13 Smith & Nephew
  74. 6.13.1 Smith & Nephew Company Information
  75. 6.13.2 Smith & Nephew Business Overview
  76. 6.13.3 Smith & Nephew Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Smith & Nephew Drug-Device Combination Products Product Portfolio
  78. 6.13.5 Smith & Nephew Recent Developments
  79. 6.14 Molnlycke
  80. 6.14.1 Molnlycke Company Information
  81. 6.14.2 Molnlycke Business Overview
  82. 6.14.3 Molnlycke Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Molnlycke Drug-Device Combination Products Product Portfolio
  84. 6.14.5 Molnlycke Recent Developments
  85. 6.15 Teleflex
  86. 6.15.1 Teleflex Company Information
  87. 6.15.2 Teleflex Business Overview
  88. 6.15.3 Teleflex Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Teleflex Drug-Device Combination Products Product Portfolio
  90. 6.15.5 Teleflex Recent Developments
  91. 6.16 BD
  92. 6.16.1 BD Company Information
  93. 6.16.2 BD Business Overview
  94. 6.16.3 BD Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 BD Drug-Device Combination Products Product Portfolio
  96. 6.16.5 BD Recent Developments
  97. 6.17 Lepu Medical
  98. 6.17.1 Lepu Medical Company Information
  99. 6.17.2 Lepu Medical Business Overview
  100. 6.17.3 Lepu Medical Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Lepu Medical Drug-Device Combination Products Product Portfolio
  102. 6.17.5 Lepu Medical Recent Developments
  103. 6.18 MicroPort
  104. 6.18.1 MicroPort Company Information
  105. 6.18.2 MicroPort Business Overview
  106. 6.18.3 MicroPort Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 MicroPort Drug-Device Combination Products Product Portfolio
  108. 6.18.5 MicroPort Recent Developments
  109. 6.19 Terumo
  110. 6.19.1 Terumo Company Information
  111. 6.19.2 Terumo Business Overview
  112. 6.19.3 Terumo Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Terumo Drug-Device Combination Products Product Portfolio
  114. 6.19.5 Terumo Recent Developments
  115. 6.20 B. Braun
  116. 6.20.1 B. Braun Company Information
  117. 6.20.2 B. Braun Business Overview
  118. 6.20.3 B. Braun Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 B. Braun Drug-Device Combination Products Product Portfolio
  120. 6.20.5 B. Braun Recent Developments
  121. 6.21 Antares Pharma
  122. 6.21.1 Antares Pharma Company Information
  123. 6.21.2 Antares Pharma Business Overview
  124. 6.21.3 Antares Pharma Drug-Device Combination Products Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Antares Pharma Drug-Device Combination Products Product Portfolio
  126. 6.21.5 Antares Pharma Recent Developments
7 North America
  1. 7.1 North America Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug-Device Combination Products Market Size by Country (2021-2026)
  3. 7.3 North America Drug-Device Combination Products Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug-Device Combination Products Market Size by Country (2021-2026)
  3. 8.3 Europe Drug-Device Combination Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug-Device Combination Products Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug-Device Combination Products Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug-Device Combination Products Market Size by Country (2021-2026)
  3. 10.3 South America Drug-Device Combination Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug-Device Combination Products Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug-Device Combination Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst